DEPRESCRIBING CARDIOVASCULAR MEDICATIONS IN OLDER ADULTS: A PRACTICAL APPROACH
- Time: 10:00am - 11:00am
- Track: Clinical Practice
- CME/CE: 1.0
Moderator: Michael W. Rich, MD
Using the framework of patient centered care exemplified by the 5Ms (Mind, Mobility, Medications, Multimorbidity and Matters Most) or the domain management model recently highlighted in the cardiology literature, this session will address the rationale, evidence, and strategies for deprescribing cardiovascular medications (e.g. statins, anticoagulants, antihypertensive agents) through the lens of improving the coordination of care between medical team members and aligning therapy with patient-centered goals. Learning Objectives: (1) describe the epidemiology and clinical sequelae of cardiovascular medication overload along with the barriers to deprescribing; (2) review the evidence base for deprescribing CV medications in older adults, including the potential adverse consequences associated with deprescribing; and (3) discuss steps to deprescribe cardiovascular medications within a patient-centered framework.
|Rationale, Triggers, Sequelae, and Clinical Trials of Deprescribing Cardiovascular Medications
Ashok Krishnaswami, MD, MAS
|Patient-Centered Cardiovascular Medication Deprescribing
Parag Goyal, MD, MSc, FACC
|Improving Cardiovascular Medication Deprescribing by the Utilization of Collaborative Practice Protocols
Andrew R. Zullo, PharmD, PhD
|Deprescribing in the Nursing Home: A Potential Model for Success?
Nicole M. Orr, MD, FACC